Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease

Dinarvand, R., Morais, P. C. D., & D'Emanuele, A. (2012). Nanoparticles for Targeted Delivery of Active Agents against Tumor Cells. Journal of Drug Delivery, 2012(), 186-187. https://doi.org/10.1155/2012/528123
Gao, Y., & Jacot, J. G. (2015). Stem Cells and Progenitor Cells for Tissue-Engineered Solutions to Congenital Heart Defects. Biomarker Insights, 2015(S1), 139-146. https://doi.org/10.4137/BMI.S20058
Cutts, J., Nikkhah, M., & Brafman, D. A. (2015). Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering. Biomarker Insights, 2015(S1), 77-90. https://doi.org/10.4137/BMI.S20313
Lee, Y. K. (2011). Pluripotent stem cells for cardiac regeneration [doctoral dissertation, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200019327
Wang, X., Zhang, J., Zhang, F., Li, J., Li, Y., Tan, Z., Hu, J., Qi, Y., Li, Q., & Yan, B. (2015). The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy. Stem Cells International, 2015(), 76-88-007. https://doi.org/10.1155/2015/135023